{"id":1681,"date":"2020-11-04T16:01:08","date_gmt":"2020-11-04T08:01:08","guid":{"rendered":"https:\/\/regask.com\/?page_id=1681"},"modified":"2024-02-24T04:28:31","modified_gmt":"2024-02-23T20:28:31","slug":"ressourcen-fallstudien-pharma-biotech","status":"publish","type":"page","link":"https:\/\/regask.com\/de\/case-studies\/resources-case-studies-pharma-biotech\/","title":{"rendered":"Pharma und Biotech"},"content":{"rendered":"<div class=\"row\"  id=\"row-1216711507\">\n\n\t<div id=\"col-1576726175\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner text-center\"  >\n\t\t\t\n\t\t\t\n<h1 style=\"text-align: center;\">Fall <strong>Studien<\/strong><\/h1>\n<p class=\"sub-title\" style=\"text-align: center;\">Kuratierte regulatorische Informationen, erg\u00e4nzt durch KI<\/p>\n<div><div class=\"menu-case-studies-container\"><ul id=\"menu-case-studies\" class=\"shortcode-menu\"><li id=\"menu-item-1868\" class=\"food-beverage-icon menu-item menu-item-type-post_type menu-item-object-page menu-item-1868\"><a href=\"https:\/\/regask.com\/de\/case-studies\/resources-case-studies-food-beverage\/\">Ern\u00e4hrung<\/a><\/li>\n<li id=\"menu-item-1871\" class=\"personal-care-icon menu-item menu-item-type-post_type menu-item-object-page menu-item-1871\"><a href=\"https:\/\/regask.com\/de\/case-studies\/resources-case-studies-personal-care-cosmetics\/\">Kosmetik &amp; K\u00f6rperpflege<\/a><\/li>\n<li id=\"menu-item-1872\" class=\"pharma-biotech-icon menu-item menu-item-type-post_type menu-item-object-page menu-item-1872\"><a href=\"https:\/\/regask.com\/de\/case-studies\/resources-case-studies-pharma-biotech\/\">Pharma und Biotech<\/a><\/li>\n<li id=\"menu-item-1870\" class=\"medical-devices menu-item menu-item-type-post_type menu-item-object-page menu-item-1870\"><a href=\"https:\/\/regask.com\/de\/case-studies\/resources-case-studies-medical-devices\/\">Medizinische Ger\u00e4te<\/a><\/li>\n<li id=\"menu-item-4999\" class=\"others menu-item menu-item-type-post_type menu-item-object-page menu-item-4999\"><a href=\"https:\/\/regask.com\/de\/case-studies\/others\/\">Sonstiges<\/a><\/li>\n<\/ul><\/div><\/div>\n<div class=\"is-divider divider clearfix\" style=\"max-width:100%;height:1px;background-color:rgb(216, 216, 216);\"><\/div>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1576726175 > .col-inner {\n  padding: 50px 0px 0px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-528410283\">\n\n\t<div id=\"col-1093772346\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\n  \n    <div class=\"row large-columns-1 medium-columns- small-columns-1 row-large\" >\n  <div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/how-pharmaceutical-companies-can-use-ai-to-stay-compliant-amid-evolving-trade-regulations\/\" class=\"plain\" aria-label=\"Wie Pharmaunternehmen KI nutzen k\u00f6nnen, um die Compliance zu gew\u00e4hrleisten \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"248\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/how-pharmaceutical-companies-use-ai-stay-compliant-amid-evolving-trade-regulations-1-330x248.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Wie Pharmaunternehmen KI nutzen, um trotz sich entwickelnder Handelsvorschriften konform zu bleiben 1\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/how-pharmaceutical-companies-use-ai-stay-compliant-amid-evolving-trade-regulations-1-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/how-pharmaceutical-companies-use-ai-stay-compliant-amid-evolving-trade-regulations-1-16x12.png 16w, https:\/\/regask.com\/wp-content\/uploads\/2025\/09\/how-pharmaceutical-companies-use-ai-stay-compliant-amid-evolving-trade-regulations-1.png 800w\" sizes=\"auto, (max-width: 330px) 100vw, 330px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/how-pharmaceutical-companies-can-use-ai-to-stay-compliant-amid-evolving-trade-regulations\/\" class=\"plain\">Wie Pharmaunternehmen KI nutzen k\u00f6nnen, um die Compliance zu gew\u00e4hrleisten \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLaut Deloittes globalem Ausblick f\u00fcr die Biowissenschaften im Jahr 2023 gaben mehr als 601.000 F\u00fchrungskr\u00e4fte aus der Biopharmabranche an, dass ihre Organisationen \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/how-pharmaceutical-companies-can-use-ai-to-stay-compliant-amid-evolving-trade-regulations\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/blogs\/\" class=\"category-blogs\">Blogs<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/\" class=\"plain\" aria-label=\"Durchf\u00fchrung globaler hybrider klinischer Studien: Vereinfacht, kom\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"248\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1-330x248.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Globale Hybrid-Studien vereinfacht konform skalierbar 1\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1-16x12.png 16w, https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png 800w\" sizes=\"auto, (max-width: 330px) 100vw, 330px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/\" class=\"plain\">Durchf\u00fchrung globaler hybrider klinischer Studien: Vereinfacht, kom\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tDie Herausforderung: Ein weltweit f\u00fchrendes Pharmaunternehmen bereitete sich auf die Skalierung hybrider klinischer Studien f\u00fcr seine Lebensmittel f\u00fcr besondere medizinische Zwecke vor \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/north-america\/united-states-regulations\/\" class=\"category-united-states-regulations\">Vereinigte Staaten<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/food-and-beverage\/\" class=\"category-food-and-beverage\">Lebensmittel und Ern\u00e4hrung<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/regalert-regulatory-monitoring\/\" class=\"plain\" aria-label=\"Pharmariese nutzte RegASK zur proaktiven \u00dcberwachung von Re\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"248\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert-330x248.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Medizin und Gift Pharma\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert-330x248.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert-870x653.png 870w, https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert-768x576.png 768w, https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert-1536x1152.png 1536w, https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert.png 1601w\" sizes=\"auto, (max-width: 330px) 100vw, 330px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/regalert-regulatory-monitoring\/\" class=\"plain\">Pharmariese nutzt RegASK zur proaktiven \u00dcberwachung von Re\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tDie Verwendung von Nahrungserg\u00e4nzungsmitteln und pflanzlichen Arzneimitteln nimmt in mehreren L\u00e4ndern weiter zu. Der Kontext ihrer Verwendung variiert jedoch \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/regalert-regulatory-monitoring\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/boosting-claims-for-a-health-product-launch\/\" class=\"plain\" aria-label=\"Werbeversprechen f\u00fcr die Markteinf\u00fchrung eines Gesundheitsprodukts verst\u00e4rken\u00a0\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"300\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/02\/Boosting-Claims-for-a-Health-Product-Launch-2.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Werbeversprechen f\u00fcr die Markteinf\u00fchrung eines Gesundheitsprodukts verst\u00e4rken\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/boosting-claims-for-a-health-product-launch\/\" class=\"plain\">Werbeversprechen f\u00fcr die Markteinf\u00fchrung eines Gesundheitsprodukts verst\u00e4rken\u00a0<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLesen Sie die Fallstudie und erfahren Sie, wie ein gro\u00dfes Unternehmen im Gesundheitswesen seine Produkteinf\u00fchrung erfolgreich optimierte und seine Werbeaussagen verst\u00e4rkte, um sie \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/boosting-claims-for-a-health-product-launch\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/pharma-regulatory-intelligence\/\" class=\"plain\" aria-label=\"F\u00f6rderung der regulatorischen Intelligenz im Pharmabereich f\u00fcr bessere\u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"300\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Pharma-Giant-Elevates-Regulatory-Change-Monitoring-with-RegAlert.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Pharmariese verbessert \u00dcberwachung regulatorischer \u00c4nderungen mit Regalert\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/pharma-regulatory-intelligence\/\" class=\"plain\">F\u00f6rderung der regulatorischen Intelligenz im Pharmabereich f\u00fcr bessere\u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tErgebnisse: Das Unternehmen erhielt einen besseren Einblick in die regulatorische Landschaft, die sich auf seine Produktkategorien auswirkt, und konnte seine Agilit\u00e4t steigern \u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/pharma-regulatory-intelligence\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/consumer-health-regulatory-risks\/\" class=\"plain\" aria-label=\"Antizipation regulatorischer Risiken und Chancen im Bereich \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"300\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Anticipating-Regulatory-Risks-and-Opportunities-in-Consumer-Health-Industry.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Antizipation regulatorischer Risiken und Chancen in der Consumer-Health-Branche\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/consumer-health-regulatory-risks\/\" class=\"plain\">Antizipation regulatorischer Risiken und Chancen im Bereich \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tLesen Sie die Fallstudie und erfahren Sie anhand dieses Praxisbeispiels, wie Sie regulatorische Risiken und Chancen im Bereich Verbrauchergesundheit und -di\u2026 antizipieren k\u00f6nnen. <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/consumer-health-regulatory-risks\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/asia-pac\/australia-regulations\/\" class=\"category-australia-regulations\">Australien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/asia-pac\/china-regulations\/\" class=\"category-china-regulations\">China<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/asia-pac\/india-regulations\/\" class=\"category-india-regulations\">Indien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/asia-pac\/indonesia-regulations\/\" class=\"category-indonesia-regulations\">Indonesien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/decentralized-clinical-trials-cros\/\" class=\"plain\" aria-label=\"Dezentrale klinische Studien: Wie CROs davon profitieren k\u00f6nnen \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"300\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/10\/Decentralized-Clinical-Trials-How-CROs-Can-Benefit-from-RegASK-Solutions.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Dezentrale klinische Studien: Wie Cros von RegASK-L\u00f6sungen profitieren kann\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/decentralized-clinical-trials-cros\/\" class=\"plain\">Dezentrale klinische Studien: Wie CROs davon profitieren k\u00f6nnen \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tDa die COVID-19-Pandemie die klinische Forschung weiterhin st\u00f6rt, besteht seitens der Pharma- und CRO-Industrie ein erh\u00f6hter Bedarf an der Umsetzung\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/decentralized-clinical-trials-cros\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/real-world-evidence-otc-claims\/\" class=\"plain\" aria-label=\"Wie Beweise aus der Praxis die Untermauerung von Behauptungen unterst\u00fctzten \u2026\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"300\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2020\/11\/POST-How-Real-World-Evidence-Supported-Claim-Substantiation-On-OTC-Product-In-Europe-And-USA-330x300.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Beitrag: Wie Beweise aus der Praxis die Untermauerung von Behauptungen zu rezeptfreien Produkten in Europa und den USA unterst\u00fctzen\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2020\/11\/POST-How-Real-World-Evidence-Supported-Claim-Substantiation-On-OTC-Product-In-Europe-And-USA-330x300.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2020\/11\/POST-How-Real-World-Evidence-Supported-Claim-Substantiation-On-OTC-Product-In-Europe-And-USA.png 689w\" sizes=\"auto, (max-width: 330px) 100vw, 330px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/real-world-evidence-otc-claims\/\" class=\"plain\">Wie Beweise aus der Praxis die Untermauerung von Behauptungen unterst\u00fctzten \u2026<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\tEin f\u00fchrendes Unternehmen der Pharmaindustrie wollte die Behauptungen zu einem rezeptfreien Produkt (OTC) mithilfe von Praxisbeweisen untermauern. <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/real-world-evidence-otc-claims\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><div class=\"col post-item\" >\n\t\t\t<div class=\"col-inner\">\n\t\t\t\t<div class=\"box box-vertical box-text-bottom box-blog-post has-hover\">\n            \t\t\t\t\t<div class=\"box-image\" style=\"width:43%;\">\n  \t\t\t\t\t\t<div class=\"image-cover\" style=\"padding-top:89%;\">\n\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/north-america-market-entry\/\" class=\"plain\" aria-label=\"Markteintritt eines Gesundheitsprodukts in Mexiko\">\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"330\" height=\"300\" src=\"https:\/\/regask.com\/wp-content\/uploads\/2020\/11\/POST-Market-Entry-to-Mexico-for-a-Health-Product-330x300.png\" class=\"attachment-medium size-medium wp-post-image\" alt=\"Nach der Markteinf\u00fchrung eines Gesundheitsprodukts in Mexiko\" srcset=\"https:\/\/regask.com\/wp-content\/uploads\/2020\/11\/POST-Market-Entry-to-Mexico-for-a-Health-Product-330x300.png 330w, https:\/\/regask.com\/wp-content\/uploads\/2020\/11\/POST-Market-Entry-to-Mexico-for-a-Health-Product.png 689w\" sizes=\"auto, (max-width: 330px) 100vw, 330px\" \/>\t\t\t\t\t\t\t<\/a>\n  \t\t\t\t\t\t\t  \t\t\t\t\t\t\t  \t\t\t\t\t\t<\/div>\n  \t\t\t\t\t\t  \t\t\t\t\t<\/div>\n          \t\t\t\t\t<div class=\"box-text text-left\" >\n\t\t\t\t\t<div class=\"box-text-inner blog-post-inner\">\n\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t<div class=\"is-divider\"><\/div>\n\n\t\t\t\t\t<h5 class=\"post-title is-xxlarge\">\n\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/north-america-market-entry\/\" class=\"plain\">Markteintritt eines Gesundheitsprodukts in Mexiko<\/a>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\t\n\t\t\t\t\t<div class=\"min-height-excerpt\">\n\t\t\t\t\t&nbsp; Nachfrage: Bewertung der Wahrscheinlichkeit einer Produktzertifizierung auf dem mexikanischen Markt. Ein gro\u00dfes chinesisches Unternehmen f\u00fcr Gesundheitsprodukte war auf der Suche nach einer Erweiterung\u2026 <br \/>\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\t<a href=\"https:\/\/regask.com\/de\/north-america-market-entry\/\" class=\"button secondary is-link is-large mb-0\">\n\t\t\t\t\t\t\tMehr lesen\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"eneko_tags_cat\"><h6 class=\"entry-category is-xsmall\"><a href=\"https:\/\/regask.com\/de\/category\/case-study\/\" class=\"category-case-study\">Fallstudien<\/a> <a href=\"https:\/\/regask.com\/de\/category\/region\/latin-america\/mexico-regulations\/\" class=\"category-mexico-regulations\">Mexiko<\/a> <a href=\"https:\/\/regask.com\/de\/category\/case-study\/pharma-and-biotech\/\" class=\"category-pharma-and-biotech\">Pharma und Biotech<\/a><\/h6><\/div>\n\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div><\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n<p class=\"text-center\"><mark>Block <strong>&quot;1346&quot;<\/strong> nicht gefunden<\/mark><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":39,"featured_media":0,"parent":548,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1681","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pharma &amp; Biotech | Regulatory Affairs Case Studies | RegASK<\/title>\n<meta name=\"description\" content=\"Read how RegASK uses Real World Evidence to support Pharma &amp; Biotech Claim Substantiation, infant formula market expansion &amp; import registration.\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma &amp; Biotech | Regulatory Affairs Case Studies | RegASK\" \/>\n<meta property=\"og:description\" content=\"Read how RegASK uses Real World Evidence to support Pharma &amp; Biotech Claim Substantiation, infant formula market expansion &amp; import registration.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/fallstudien\/ressourcen-fallstudien-pharma-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-23T20:28:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1601\" \/>\n\t<meta property=\"og:image:height\" content=\"1201\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Pharma &amp; Biotech | Regulatory Affairs Case Studies | RegASK\" \/>\n<meta name=\"twitter:description\" content=\"Read how RegASK uses Real World Evidence to support Pharma &amp; Biotech Claim Substantiation, infant formula market expansion &amp; import registration.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert.png\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/case-studies\\\/resources-case-studies-pharma-biotech\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/case-studies\\\/resources-case-studies-pharma-biotech\\\/\",\"name\":\"Pharma & Biotech | Regulatory Affairs Case Studies | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"datePublished\":\"2020-11-04T08:01:08+00:00\",\"dateModified\":\"2024-02-23T20:28:31+00:00\",\"description\":\"Read how RegASK uses Real World Evidence to support Pharma & Biotech Claim Substantiation, infant formula market expansion & import registration.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/regask.com\\\/case-studies\\\/resources-case-studies-pharma-biotech\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/case-studies\\\/resources-case-studies-pharma-biotech\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/regask.com\\\/case-studies\\\/resources-case-studies-pharma-biotech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Case Studies\",\"item\":\"https:\\\/\\\/regask.com\\\/case-studies\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma and Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma &amp; Biotechnologie | Fallstudien zu regulatorischen Angelegenheiten | RegASK","description":"Lesen Sie, wie RegASK Real World Evidence nutzt, um die Begr\u00fcndung von Behauptungen in der Pharma- und Biotechnologiebranche, die Markterweiterung f\u00fcr S\u00e4uglingsnahrung und die Importregistrierung zu unterst\u00fctzen.","robots":{"index":"noindex","follow":"follow"},"og_locale":"de_DE","og_type":"article","og_title":"Pharma & Biotech | Regulatory Affairs Case Studies | RegASK","og_description":"Read how RegASK uses Real World Evidence to support Pharma & Biotech Claim Substantiation, infant formula market expansion & import registration.","og_url":"https:\/\/regask.com\/de\/fallstudien\/ressourcen-fallstudien-pharma-biotech\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_modified_time":"2024-02-23T20:28:31+00:00","og_image":[{"width":1601,"height":1201,"url":"https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_title":"Pharma & Biotech | Regulatory Affairs Case Studies | RegASK","twitter_description":"Read how RegASK uses Real World Evidence to support Pharma & Biotech Claim Substantiation, infant formula market expansion & import registration.","twitter_image":"https:\/\/regask.com\/wp-content\/uploads\/2022\/02\/pharma-giant-elevated-regulatory-change-monitoring-with-regalert.png","twitter_site":"@ASKRegASK","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/regask.com\/case-studies\/resources-case-studies-pharma-biotech\/","url":"https:\/\/regask.com\/case-studies\/resources-case-studies-pharma-biotech\/","name":"Pharma &amp; Biotechnologie | Fallstudien zu regulatorischen Angelegenheiten | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"datePublished":"2020-11-04T08:01:08+00:00","dateModified":"2024-02-23T20:28:31+00:00","description":"Lesen Sie, wie RegASK Real World Evidence nutzt, um die Begr\u00fcndung von Behauptungen in der Pharma- und Biotechnologiebranche, die Markterweiterung f\u00fcr S\u00e4uglingsnahrung und die Importregistrierung zu unterst\u00fctzen.","breadcrumb":{"@id":"https:\/\/regask.com\/case-studies\/resources-case-studies-pharma-biotech\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/case-studies\/resources-case-studies-pharma-biotech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/regask.com\/case-studies\/resources-case-studies-pharma-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Case Studies","item":"https:\/\/regask.com\/case-studies\/"},{"@type":"ListItem","position":2,"name":"Pharma and Biotech"}]},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages\/1681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=1681"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages\/1681\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/pages\/548"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=1681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}